T

Tenax Therapeutics
D

TENX

5.11000
USD
0.01
(0.20%)
Market Open
Volume
114
EPS
-7
Div Yield
-
P/E
-0
Market Cap
17,419,510
OverviewSignalsIdeasNews
Related Instruments
    MCO
    MCO
    -8.87
    (-1.84%)
    473.28 USD
    P
    PAY
    0.985
    (3.02%)
    33.560 USD
    More
News

Title: Tenax Therapeutics

Sector: Healthcare
Industry: Biotechnology
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North Americanrights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved EjectionFraction.